MARKET

SNES

SNES

SenesTech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5539
+0.0138
+2.56%
Closed 17:41 12/13 EST
OPEN
0.5425
PREV CLOSE
0.5401
HIGH
0.5557
LOW
0.5270
VOLUME
139.38K
TURNOVER
--
52 WEEK HIGH
1.950
52 WEEK LOW
0.5200
MARKET CAP
15.67M
P/E (TTM)
-1.3903
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SNES and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SNES News

  • SNES: Encouraging quarterly earnings results. Expect an uptick in sales in 2020.
  • Zacks Small Cap Research.11/19 17:10
  • SNES: Results for the Washington DC project are very encouraging. ContraPest deployment in San Francisco and Los Angeles have been initiated. 2Q19 financials were close to our expectations.
  • Zacks Small Cap Research.11/13 16:15
  • SenesTech's (SNES) CEO Ken Siegel on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/13 03:36
  • SenesTech EPS misses by $0.05, revenue in-line
  • seekingalpha.11/13 02:17

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About SNES

SenesTech, Inc. is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest's technology and approach targets the reproductive capabilities of both sexes. Using bait stations, ContraPest is dispensed in a palatable liquid formulation that promotes sustained consumption by rodent communities. Its formulation causes both female and male rats to become infertile once they have consumed the dose. The active ingredient in females accelerates the rate at which ovarian follicles (egg structures) are depleted. Once these cells are gone, the animal cannot reproduce. In males, there is a marked reduction in the ability to fertilize eggs and, often complete sterility. ContraPest is designed, formulated and dispensed for handlers and non-target species, such as wildlife and pets in a biodegradable product.
More

Webull offers SenesTech Inc (SNES) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.